Amicus Therapeutics, Inc. (FOLD)
14.49
0.00 (0.00%)
USD |
NASDAQ |
Apr 28, 16:00
Amicus Therapeutics Research and Development Expense (TTM) : 135.84M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Insmed, Inc. | 771.09M |
| Ligand Pharmaceuticals, Inc. | 81.18M |
| PTC Therapeutics, Inc. | 455.25M |
| Establishment Labs Holdings, Inc. | 20.25M |